Eton Pharmaceuticals, Inc. (ETON) key performance indicators and operating metrics (6 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 5.7M | FY2026-Q1 |
| Adjusted Gross Profit | 16.2M | FY2026-Q1 |
| Adjusted Gross Profit Margin | 67.00 percent | FY2026-Q1 |
| Diluted Earnings Per Share (Non-GAAP) | 0.14 USD_per_share | FY2026-Q1 |
| Net Product Sales and Royalty Revenues | 24.3M | FY2026-Q1 |
| Total Product Revenue | 22.5M | FY2025-Q3 |
Back to ETON overview · ETON earnings · ETON holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.